Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk

• Main Authors: Jun-Feng Li (Author), Xiang Qu (Author), Zhan Gao (Author), Chang-Xi Chen (Author), Feng-Yu Zhang (Author), Ling Cheng (Author), Xi Zhou (Author), Hao Zhou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aims: Few studies have compared the association between dosing of spironolactone and outcomes in patients with heart failure with preserved ejection fraction (HFpEF), and whether spironolactone dose could significantly affect the prognosis of HFpEF patients combined with chronic kidney disease (CKD)...